C07D 223 - Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom

Patents for C07D 223 - Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom (8,732)
01/2000
01/27/2000	WO2000004020A1 Compounds, compositions, and methods for stimulating neuronal growth and elongation
01/27/2000	WO1999063930A3 Novel angiotensin receptor modulators and their uses
01/27/2000	CA2337377A1 Compounds, compositions, and methods for stimulating neuronal growth and elongation
01/26/2000	CN1048718C Phenylethyl and phenylpropylamines compounds, prepn. method, pharmaceutical agent and use thereof
01/20/2000	WO1999048897B1 Synthesis of compounds and libraries of compounds
01/19/2000	CN1242007A Cycloalkyl, lactam lactone and related compounds as 'beta'-amyloid peptide release inhibitors
01/19/2000	CN1048484C A process for preparing a composition containing benzoheterocycles
01/18/2000	CA2118174C Galanthamine derivatives, a process for their preparation and their use as medicaments
01/13/2000	WO2000001670A1 Substituted nitrogen and sulfur alicyclic compounds, including methods for synthesis thereof
01/13/2000	CA2356841A1 Substituted nitrogen and sulfur alicyclic compounds, including methods for synthesis thereof
01/11/2000	US6013651 Meta-azacyclic amino benzoic acid compounds and derivatives thereof
01/05/2000	EP0968201A2 New aminopiperazine derivatives
01/05/2000	EP0968198A1 HETEROCYCLIC COMPOUNDS AND THEIR USE FOR INHIBITING $g(b)-AMYLOID PEPTIDE
01/05/2000	EP0787115B1 PROCESS FOR PRODUCING DERIVATIVES OF 4a,5,9,10,11,12,-HEXAHYDRO-6H-BENZOFURO[3a,3,2-ef][2]BENZAZEPINE
01/04/2000	US6011028 Cyclic amidino agents useful as nitric oxide synthase inhibitors
01/04/2000	CA2118172C Galanthamine derivatives, a process for their preparation and their use as medicaments
12/1999
12/29/1999	WO1999067230A1 INHIBITORS OF α4β1 MEDIATED CELL ADHESION
12/29/1999	WO1999067221A1 Compounds for inhibiting beta-amyloid peptide release and/or its synthesis
12/29/1999	WO1999067220A1 Compounds for inhibiting beta-amyloid peptide release and/or its synthesis
12/29/1999	WO1999067219A1 Compounds for inhibiting beta-amyloid peptide release and/or its synthesis
12/29/1999	WO1999067214A1 Method for evaporating aminonitrile
12/29/1999	WO1999066944A1 Methods for identifying novel multimeric agents that modulate receptors
12/29/1999	WO1999066934A1 CYCLIC AMINO ACID COMPOUNDS, PHARMACEUTICAL COMPOSITIONS COMPRISING SAME, AND METHODS FOR INHIBITING β-AMYLOID PEPTIDE RELEASE AND/OR ITS SYNTHESIS BY USE OF SUCH COMPOUNDS
12/29/1999	CN1239744A Caprolactum recovering process from nylon-6 fiber washing water
12/29/1999	CA2342778A1 Inhibitors of .alpha.4.beta.1 mediated cell adhesion
12/29/1999	CA2337137A1 Method for evaporating aminonitrile
12/29/1999	CA2325389A1 Compounds for inhibiting beta-amyloid peptide release and/or its synthesis
12/29/1999	CA2325388A1 Compounds for inhibiting beta-amyloid peptide release and/or its synthesis
12/29/1999	CA2324475A1 Cyclic amino acid compounds, pharmaceutical compositions comprising same, and methods for inhibiting .beta.-amyloid peptide release and/or its synthesis by use of such compounds
12/29/1999	CA2324474A1 Compounds for inhibiting beta-amyloid peptide release and/or its synthesis
12/29/1999	CA2319650A1 Methods for identifying novel multimeric agents that modulate receptors
12/28/1999	US6008214 Inhibiting platelet aggregation and bone resorption, treating stroke, transient ischemia attacks, or myocardial infarction, treating osteoporosis
12/28/1999	CA2118171C Galanthamine derivatives, a process for their preparation and their use as medicaments
12/22/1999	EP0964847A1 Method for separating an imine from a mixture containing an amine and an imine
12/22/1999	EP0964683A1 Leukotriene antagonists for oral squamous cell carcinoma
12/21/1999	CA2006577C Hypoglycaemic phenylamidines and phenylguanidines
12/16/1999	WO1999064394A1 Neuropeptide y5 receptor antagonists
12/16/1999	WO1999064055A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht4 receptors
12/16/1999	WO1999064053A1 β3-ADRENERGIC RECEPTOR AGONISTS
12/16/1999	WO1999064052A1 Novel leukotriene receptor antagonists and their uses
12/16/1999	WO1999064042A1 Novel therapeutic agents that modulate alpha-1a adrenergic receptors
12/16/1999	WO1999064041A1 Multibinding agents that modulate nmda receptors
12/16/1999	WO1999064038A1 Novel analgesic agents
12/16/1999	WO1999064035A1 β2-ADRENERGIC RECEPTOR AGONISTS
12/16/1999	WO1999064034A1 β2-ADRENERGIC RECEPTOR AGONISTS
12/16/1999	WO1999064031A1 β2-ADRENERGIC RECEPTOR AGONISTS
12/16/1999	WO1999064000A1 Novel therapeutic agents that modulate neurokinin receptors
12/16/1999	WO1999063999A1 H1-histamine receptor antagonists
12/16/1999	WO1999063996A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht2 receptors
12/16/1999	WO1999063993A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the d1 receptors
12/16/1999	WO1999063983A1 MULTIBINDING AGENTS THAT MODULATE PPARη AND RXR RECEPTORS
12/16/1999	WO1999063944A2 Novel therapeutic agents that modulate estrogen receptors
12/16/1999	WO1999063936A2 Novel therapeutic agents that modulate endothelin receptors
12/16/1999	WO1999063933A2 Multivalent agonists, partial agonists and antagonists of the gaba receptors
12/16/1999	WO1999063930A2 Novel angiotensin receptor modulators and their uses
12/16/1999	CA2321273A1 Novel analgesic agents
12/16/1999	CA2321170A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the d1 receptors
12/16/1999	CA2321152A1 Novel therapeutic agents that modulate endothelin receptors
12/16/1999	CA2321120A1 .beta.3-adrenergic receptor agonists
12/16/1999	CA2320926A1 Novel leukotriene receptor antagonists and their uses
12/16/1999	CA2319756A1 Novel therapeutic agents that modulate alpha-1a adrenergic receptors
12/16/1999	CA2319751A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht2 receptors
12/16/1999	CA2319651A1 H1-histamine receptor antagonists
12/16/1999	CA2319643A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht4 receptors
12/16/1999	CA2319497A1 Novel therapeutic agents that modulate estrogen receptors
12/16/1999	CA2319496A1 Multivalent agonists, partial agonists and antagonists of the gaba receptors
12/16/1999	CA2319175A1 Multibinding agents that modulate nmda receptors
12/16/1999	CA2319159A1 Novel therapeutic agents that modulate neurokinin receptors
12/16/1999	CA2319068A1 Novel angiotensin receptor modulators and their uses
12/16/1999	CA2318894A1 .beta.2-adrenergic receptor agonists
12/16/1999	CA2318286A1 Multibinding agents that modulate ppar.gamma. and rxr receptors
12/16/1999	CA2318055A1 .beta.2-adrenergic receptor agonists
12/15/1999	CN1238689A Vitronectin receptor antagonists
12/14/1999	US6001393 Ginkgo biloba extract enhanced bioavailability composition and food products
12/09/1999	WO1999062881A1 Aza-heterocyclic compounds used to treat neurological disorders and hair loss
12/09/1999	WO1999062880A1 N-linked sulfonamides of n-heterocyclic carboxylic acids or carboxylic acid isosteres
12/09/1999	WO1999062879A1 Ureas and carbamates of n-heterocyclic carboxylic acids and carboxylic acid isosteres
12/09/1999	CA2334002A1 N-linked sulphonamides of n-heterocyclic carboxylic acids or carboxylic acid isosteres
12/09/1999	CA2333960A1 Ureas and carbamates of n-heterocyclic carboxylic acids and carboxylic acid isosteres
12/08/1999	EP0961768A1 Method for separating 6-aminocaproic acid nitrile from mixtures containing 6-aminocaproic acid nitrile and an imine
12/08/1999	EP0961617A1 Leukotriene antagonists for cerebral focal stroke
12/02/1999	WO1999061424A1 Conformationally constrained amino acid compounds having affinity for the alpha2delta subunit of a calcium channel
12/02/1999	WO1999061414A1 Novel substituted guanidine derivatives and process for producing the same
12/02/1999	WO1999048872A3 Method for separating an azepine derivative from a mixture containing an amine and an azepine derivative
12/02/1999	CA2331509A1 Novel substituted guanidine derivatives and process for producing the same
12/01/1999	EP0800504B1 Tricyclic retinoids, methods for their production and use
11/1999
11/30/1999	US5994537 Process for preparing azepinone compounds useful in the inhibition of ACE and NEP
11/30/1999	US5994284 Imidoperoxycarboxylic acids, their use in detergents and cleaning agents
11/25/1999	WO1999059959A1 Benzamide derivatives for the treatment of diseases mediated by cytokines
11/24/1999	EP0957917A1 Vitronectin receptor antagonists
11/24/1999	EP0957913A1 N-linked sulfonamides of heterocyclic thioesters
11/18/1999	WO1999058501A1 Compounds with growth hormone releasing properties
11/16/1999	US5986092 Dehydrohalogenation, basification and phase transfer catalyst
11/16/1999	US5985869 Benzoheterocyclic compounds
11/11/1999	WO1999048897A3 Synthesis of compounds and libraries of compounds
11/09/1999	US5981521 Tetrahydroisoquinoline derivatives as LHRH antagonists
11/09/1999	US5981511 Hydroxyamidino derivatives useful as nitric oxide synthase inhibitors
11/09/1999	CA2106452C Amidinophenol derivatives
11/04/1999	WO1999055690A1 Guanidine derivatives
11/04/1999	WO1999055355A1 Amino acid amidinohydrazones, alkoxyguanidines and aminoguanidines as protease inhibitors

1 ... 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 ... 88